Job Description

At Bristol Myers Squibb, we are inspired by a single vision transforming patients lives through science. In oncology, hematology, immunology and cardiovascular disease and one of the most diverse and promising pipelines in the industry each of our passionate colleagues contribute to innovations that drive meaningful change. We bring a human touch to every treatment we pioneer. Join us and make a difference.

The BMS Immuno-Oncology and Cell Therapy Thematic Research Center is dedicated to research supporting development of novel cellular therapies. Our goal is to revolutionize medicine by re-engaging the bodys immune system to treat cancer.

The Cell Therapy Engineering and Gene Editing Team is seeking a highly motivated, dynamic and self-driven individual to help us deliver on this critical goal and drive the development of our non-viral delivery platform for gene editing applications in cell therapy. The ideal candidate is an experienced molecular and cellular biologist with a strong background in technology development and T cell immunology. The successful candidate will have in-depth conceptual and practical understanding of gene editing technologies and significant experience in non-viral delivery of genetic material to primary cells as well as an understanding of key challenges related to non-viral delivery. Additionally, the candidate should have a solid grasp on DNA repair and DNA sensing pathways in immune cells. This role will provide a challenging but rewarding opportunity for career development and is ideal for a scientist with an innovative cell engineering mindset. A previous experience in cellular therapy, industry or academic, is preferred.

Responsibilities include but are not limited to:

* Develop innovative non-viral delivery strategies for gene editing applications.
* Design experiments, organize and analyze results and communicate progress to the group.
* Evaluate and prioritize non-viral engineering strategies and deliver complete data packages to allow for timely Go/No Go decisions.
* Collaborate with SME, inside and outside the team, to evaluate the functional impact of proposed non-viral engineering strategies on CAR and eTCR cell products.
* Interface with the cell therapy development organization to evaluate at-scale feasibility/performances of research-scale proof-of-concepts.
* Work with other team members to modify gene editing protocols (for single and multiplexed gene editing applications) and to implement novel non-viral strategies in ongoing programs.
* Supervise Associate Scientist(s) and/or Research Associate(s) as needed, and under the direct, but limited supervision of management.
* Understand the context, impact and timely communication of data.

Required Qualifications.

* Ph.D. degree in Bioengineering, Molecular and Cellular Biology, Molecular Immunology, Cancer Biology or Chemical Engineering with at least 3 years of successful post-doctoral experience, evidenced by a strong publication record, plus a minimum of 3 years of successful experience as a bench scientist preferably in the biotechnology or pharmaceutical industry setting or a Masters degree with at least 12 years work experience or Bachelors degree in scientific discipline with at least 14 years work experience.
* Strong expertise in non-viral nucleic acid delivery to primary cells, preferably T cells.
* Deep understanding of cellular uptake mechanisms related to non-viral nucleic acid delivery.
* Extensive experience with gene editing technologies (CRISPR-based preferred) in human cell lines and primary cells.
* Ability to multitask, independently organize time, and plan specifics of work.
* Excellent communication and facilitation skills demonstrated in a team environment.
* Detail-oriented with the ability to identify and implement creative solutions.
* Willingness to think outside the box, be creative and ability to work in a very fast paced, ever changing environment.

Preferred Qualifications.

* Industry experience in adoptive engineered T-cell therapeutics (CAR-T or eTCR).
* Experience with viral and non-viral gene delivery for gene therapy products.
* Experience with in vitro technologies typically employed to assess T cell functionality including but not limited to MSD, IncuCyte-based assays, multi-parameter flow cytometry for phenotypic characterization of T cells, T cell activation assays, T cell proliferation analysis, imaging.
* Experience with small molecule screens in the context of CRISPR-based genetic modulation.

Around the world, we are passionate about making an impact on the lives of patients with serious diseases. Empowered to apply our individual talents and diverse perspectives in an inclusive culture, our shared values of passion, innovation, urgency, accountability, inclusion and integrity bring out the highest potential of each of our colleagues.

Bristol Myers Squibb recognizes the importance of balance and flexibility in our work environment. We offer a wide variety of competitive benefits, services and programs that provide our employees with the resources to pursue their goals, both at work and in their personal lives.

Our company is committed to ensuring that people with disabilities can excel through a transparent recruitment process, reasonable workplace adjustments and ongoing support in their roles. Applicants can request an approval of accommodation prior to accepting a job offer. If you require reasonable accommodation in completing this application, or any part of the recruitment process direct your inquiries to adastaffingsupport@bms.com. Visit careers.bms.com/eeo-accessibility to access our complete Equal Employment Opportunity statement.